BRCA1 and cancer: Out of the total 7,919 samples containing 4,278 cancer patients and 3,641 cancer-free individuals, 729 were detected with BRCA1/2 deleterious germline mutations, of which 539 individuals carried BRCA1 mutations and 213 carried BRCA2 mutations.